Inventor · disambiguated record
Gorka Etxebarria I Jardi
Also filed as: ETXEBARRIA I JARDI GORKA
19 granted patents·6 pending applications·157 citations·filing 2013–2024
94Inventor score
Top patents by PatentIndex Score
25 records- 0197US9718827B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2016·Granted Aug 1, 2017·22 cites·6 claims
- 0297US9340546B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2013·Granted May 17, 2016·57 cites·6 claims
- 0396US8957078B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2013·Granted Feb 17, 2015·19 cites·82 claims
- 0494US9650381B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2014·Granted May 16, 2017·19 cites·82 claims
- 0593US10787452B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2017·Granted Sep 29, 2020·5 cites·20 claims
- 0692US9670215B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2015·Granted Jun 6, 2017·11 cites·3 claims
- 0790US2025223292A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 0889US11117900B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2019·Granted Sep 14, 2021·2 cites·17 claims
- 0989US10815239B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2018·Granted Oct 27, 2020·3 cites·25 claims
- 1088US10392391B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2017·Granted Aug 27, 2019·4 cites·20 claims
- 1187US11370798B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2020·Granted Jun 28, 2022·1 cites·13 claims
- 1287US10800781B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2018·Granted Oct 13, 2020·2 cites·18 claims
- 1384US10093676B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2017·Granted Oct 9, 2018·3 cites·19 claims
- 1483US10793563B2GCN2 inhibitors and uses thereofMERCK PATENT GMBH·Filed 2019·Granted Oct 6, 2020·3 cites·28 claims
- 1582US12187731B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2022·Granted Jan 7, 2025·0 cites·19 claims
- 1680US10988477B2GCN2 inhibitors and uses thereofMERCK PATENT GMBH·Filed 2019·Granted Apr 27, 2021·3 cites·20 claims
- 1780US2025059190A1Gcn2 inhibitors and uses thereofMERCK PATENT GMBH·Filed 2024·Application pending·0 cites
- 1879US10160760B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2014·Granted Dec 25, 2018·3 cites·63 claims
- 1968US11485739B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2020·Granted Nov 1, 2022·0 cites·18 claims
- 2062US12084438B2GCN2 inhibitors and uses thereofMERCK PATENT GMBH·Filed 2020·Granted Sep 10, 2024·0 cites·25 claims
- 2162US2015158868A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 2259US2022340577A1Gcn2 inhibitors and uses thereofMERCK PATENT GMBH·Filed 2020·Application pending·0 cites
- 2354US2016326180A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2016·Application pending·0 cites
- 2451US2015291601A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 2545US9663519B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2013·Granted May 30, 2017·0 cites·72 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →